But Paramount has reportedly been eyeing WBD for years and followed December's merger announcement with an aggressive hostile takeover bid. On Tuesday, in addition to raising its offer to buy all of WBD, Paramount also agreed to pay a $7 billion regulatory termination fee should a Paramount-WBD merger fail to close due to antitrust regulation, as well as a $0.25 per share ticking fee for every quarter that the deal doesn’t close, starting on September 30.
「這些東西是我從來沒有經歷過，所以當時對我的心裡影響其實蠻大的，」關恆說，那些攻擊謾罵為他帶來的負面影響，加上沒有家人和朋友可以在身邊讓他傾訴，「所以我其實就是…我就不想再去面對這些事情，就是因為我當時已經是够焦頭爛額。」，详情可参考51吃瓜
Nature, Published online: 24 February 2026; doi:10.1038/d41586-026-00298-1，更多细节参见一键获取谷歌浏览器下载
Experimental therapy of applying stem cells during surgery could be ‘major milestone’ in treatment of birth defects